Cargando…
Cancer Epigenetics: New Therapies and New Challenges
Cancer is nowadays considered to be both a genetic and an epigenetic disease. The most well studied epigenetic modification in humans is DNA methylation; however it becomes increasingly acknowledged that DNA methylation does not work alone, but rather is linked to other modifications, such as histon...
Autores principales: | Hatzimichael, Eleftheria, Crook, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600296/ https://www.ncbi.nlm.nih.gov/pubmed/23533770 http://dx.doi.org/10.1155/2013/529312 |
Ejemplares similares
-
Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update
por: Hatzimichael, Eleftheria, et al.
Publicado: (2014) -
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer
por: Coley, Helen M., et al.
Publicado: (2012) -
Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
por: Hatzimichael, Eleftheria, et al.
Publicado: (2022) -
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
por: Dranitsaris, George, et al.
Publicado: (2012) -
Hematopoietic stem cell transplantation
por: Hatzimichael, Eleftheria, et al.
Publicado: (2010)